Nutex Health (NUTX) Liabilities and Shareholders Equity (2010 - 2026)

Nutex Health has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $957.3 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $957.3 million, up 25.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 61.6% YoY), and the FY2025 annual result was $918.5 million, up 40.16% from the prior year.
• Liabilities and Shareholders Equity came in at $957.3 million for Q1 2026 at Nutex Health, up from $918.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $964.5 million in Q3 2025 to a low of $83.3 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $438.5 million (2024), against an average of $583.9 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 1026.99% in 2022 and tumbled 49.96% in 2023, its largest moves.
• Nutex Health's Liabilities and Shareholders Equity stood at $431.8 million in 2022, then declined by 7.76% to $398.2 million in 2023, then surged by 64.55% to $655.3 million in 2024, then surged by 40.16% to $918.5 million in 2025, then gained by 4.22% to $957.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $957.3 million (Q1 2026), $918.5 million (Q4 2025), and $964.5 million (Q3 2025), per Business Quant data.